JO3172B1 - تركيبة وطريقة وتحضير الصفراء الصناعية - Google Patents
تركيبة وطريقة وتحضير الصفراء الصناعيةInfo
- Publication number
- JO3172B1 JO3172B1 JOP/2008/0286A JOP20080286A JO3172B1 JO 3172 B1 JO3172 B1 JO 3172B1 JO P20080286 A JOP20080286 A JO P20080286A JO 3172 B1 JO3172 B1 JO 3172B1
- Authority
- JO
- Jordan
- Prior art keywords
- preparation
- acid composition
- bile acid
- synthetic bile
- synthetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
يتعلق الاختراع الحالي بأحماض صفراوية وتركيبات وطرق لتخليقها واستخدامها. وعلى نحو أكثر تحديداً، يتعلق الاختراع بحمض ديوكسي كوليك والتركيبات ذات الصلة، حيث تكون التركيبات المذكورة خالية من جميع الشقوق ذات الأصل الحيواني وخالية من شقوق مولدة للسخونة.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94503507P | 2007-06-19 | 2007-06-19 | |
US95687507P | 2007-08-20 | 2007-08-20 | |
US12/035,339 US20080318870A1 (en) | 2007-06-19 | 2008-02-21 | Synthetic bile acid compositions and methods |
GB0807615A GB2452358C (en) | 2008-04-25 | 2008-04-25 | Preparation of bile acids. |
US12/153,446 US7902387B2 (en) | 2008-04-25 | 2008-05-16 | Preparation of bile acids and intermediates thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3172B1 true JO3172B1 (ar) | 2018-03-08 |
Family
ID=41226994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2008/0286A JO3172B1 (ar) | 2007-06-19 | 2008-06-18 | تركيبة وطريقة وتحضير الصفراء الصناعية |
Country Status (28)
Country | Link |
---|---|
EP (3) | EP2069383A2 (ar) |
JP (2) | JP2010530876A (ar) |
KR (7) | KR20160025044A (ar) |
CN (4) | CN108191940B (ar) |
AR (1) | AR067440A1 (ar) |
AU (1) | AU2008265721B2 (ar) |
BR (1) | BRPI0813140C1 (ar) |
CA (2) | CA2690841C (ar) |
CR (2) | CR20170070A (ar) |
CY (1) | CY1116700T1 (ar) |
DK (1) | DK2407475T3 (ar) |
EA (1) | EA020806B1 (ar) |
ES (2) | ES2826429T3 (ar) |
HK (2) | HK1165807A1 (ar) |
HR (1) | HRP20150879T1 (ar) |
HU (1) | HUE025909T2 (ar) |
IL (1) | IL202203B (ar) |
JO (1) | JO3172B1 (ar) |
MX (2) | MX2009013664A (ar) |
MY (1) | MY160040A (ar) |
NZ (1) | NZ581081A (ar) |
PL (1) | PL2407475T3 (ar) |
PT (1) | PT2407475E (ar) |
SI (1) | SI2407475T1 (ar) |
SM (1) | SMP201000003B (ar) |
TW (2) | TWI503327B (ar) |
WO (1) | WO2008157635A2 (ar) |
ZA (1) | ZA200907928B (ar) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080318870A1 (en) | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
JOP20180077A1 (ar) | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
EP2069383A2 (en) * | 2007-06-19 | 2009-06-17 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid composition, method, and preparation |
US8242294B2 (en) | 2007-06-19 | 2012-08-14 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
GB2480632A (en) * | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
US9127036B2 (en) | 2010-08-12 | 2015-09-08 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
ES2746311T3 (es) * | 2011-06-16 | 2020-03-05 | Allergan Sales Llc | Composiciones que contienen ácido desoxicólico y agua desionizada al 10 % en etanol, dirigidas a la purificación del ácido desoxicólico |
US20130102580A1 (en) * | 2011-09-22 | 2013-04-25 | Kythera Biopharmaceuticals, Inc. | Compositions and methods related to deoxycholic acid and its polymorphs |
US10081592B2 (en) | 2012-03-23 | 2018-09-25 | The Board Of Trustees Of The University Of Illinois | Complex and structurally diverse compounds |
CN103059087B (zh) * | 2012-12-30 | 2015-10-14 | 中山百灵生物技术有限公司 | 一种脱氧胆酸的合成方法 |
KR101447901B1 (ko) * | 2013-04-16 | 2014-10-16 | 한양대학교 산학협력단 | 지방세포 표적 비바이러스성 유전자 전달체 |
BR112018001869A2 (pt) | 2015-07-30 | 2018-09-18 | Intercept Pharmaceuticals Inc | método para preparação de ácidos biliares e derivados dos mesmos |
US20170119794A1 (en) * | 2015-11-04 | 2017-05-04 | Kythera Biopharmaceuticals, Inc. | Treatments of accumulated fat with deoxycholic acid and salts thereof |
EP3464315B1 (en) | 2016-06-06 | 2021-09-29 | Crystal Pharma S.A.U. | Methods for the preparation of deoxycholic acid, and intermediates useful in the preparation of deoxycholic acid |
EP3645548B1 (en) * | 2017-08-03 | 2023-11-29 | Medytox Inc. | Methods for preparing bile acids |
CN111511755A (zh) * | 2017-10-24 | 2020-08-07 | 比奥尼斯有限责任公司 | 脱氧胆酸的制备 |
RU2705314C1 (ru) * | 2019-03-18 | 2019-11-06 | Федеральное бюджетное учреждение науки "Государственный научный центр прикладной микробиологии и биотехнологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ПМБ) | Способ производства сухих очищенных солей желчных кислот для бактериологии |
KR102456989B1 (ko) * | 2020-06-12 | 2022-10-21 | (주)케어젠 | 항비만 활성을 가지는 디옥시콜산-펩타이드 결합체 및 이의 용도 |
KR20230043128A (ko) * | 2020-09-18 | 2023-03-30 | 서울대학교산학협력단 | 소디움 타우로디옥시콜레이트의 대량 생산 방법 |
KR20230013005A (ko) | 2021-07-16 | 2023-01-26 | 주식회사 스카이테라퓨틱스 | 담즙산 또는 담즙산 염의 분자 회합체를 포함하는 화장료 조성물 |
WO2023287260A1 (ko) | 2021-07-16 | 2023-01-19 | 주식회사 스카이테라퓨틱스 | 담즙산 또는 담즙산 염의 분자 회합체 및 이를 포함하는 국소지방제거용 의약 조성물 |
CN114478676A (zh) * | 2022-02-18 | 2022-05-13 | 国药集团化学试剂有限公司 | 一种高纯脱氧胆酸钠的制备方法 |
CN115974949B (zh) * | 2022-10-26 | 2023-12-22 | 湖南科瑞生物制药股份有限公司 | 一种植物源脱氧胆酸中间体的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2321598A (en) * | 1940-10-07 | 1943-06-15 | George A Breon & Company Inc | Preparation of desoxycholic acid |
US2615902A (en) * | 1950-10-24 | 1952-10-28 | Merck & Co Inc | Chemical compounds and processes for preparing the same |
US4113882A (en) * | 1974-10-21 | 1978-09-12 | Yamanouchi Pharmaceutical Co., Ltd. | Stabilized oral prostaglandin formulation and the process for the preparation thereof |
US4866044A (en) * | 1985-07-09 | 1989-09-12 | Takeda Chemical Industries, Ltd. | Solubilized composition of poorly-soluble pharmaceutical product |
IL89880A (en) * | 1988-04-08 | 1994-06-24 | Roussel Uclaf | A9-Hydroxy-71-Methylene steroids, their preparation and use in the synthesis of Corsican steroids |
FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
GB9910934D0 (en) * | 1999-05-11 | 1999-07-14 | Res Inst Medicine Chem | Chemical compounds |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US7754230B2 (en) | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
PL2422789T3 (pl) * | 2004-05-19 | 2018-09-28 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Wstrzykiwalna kompozycja zawierająca deoksycholan sodu |
ATE550031T1 (de) * | 2005-06-06 | 2012-04-15 | Univ Georgetown | Zusammensetzungen und verfahren für die lipomodellierung |
EP2069383A2 (en) * | 2007-06-19 | 2009-06-17 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid composition, method, and preparation |
-
2008
- 2008-06-18 EP EP08771400A patent/EP2069383A2/en not_active Ceased
- 2008-06-18 HU HUE11181831A patent/HUE025909T2/en unknown
- 2008-06-18 JP JP2010513387A patent/JP2010530876A/ja not_active Withdrawn
- 2008-06-18 AU AU2008265721A patent/AU2008265721B2/en not_active Ceased
- 2008-06-18 CN CN201810072485.3A patent/CN108191940B/zh not_active Expired - Fee Related
- 2008-06-18 ES ES15173458T patent/ES2826429T3/es active Active
- 2008-06-18 KR KR1020167004581A patent/KR20160025044A/ko active Application Filing
- 2008-06-18 CN CN200880019212A patent/CN101711254A/zh active Pending
- 2008-06-18 KR KR1020137027503A patent/KR20130133881A/ko active Search and Examination
- 2008-06-18 PL PL11181831T patent/PL2407475T3/pl unknown
- 2008-06-18 PT PT111818316T patent/PT2407475E/pt unknown
- 2008-06-18 CA CA2690841A patent/CA2690841C/en not_active Expired - Fee Related
- 2008-06-18 DK DK11181831.6T patent/DK2407475T3/en active
- 2008-06-18 TW TW097122750A patent/TWI503327B/zh active
- 2008-06-18 CN CN201610262578.3A patent/CN106146594A/zh active Pending
- 2008-06-18 NZ NZ581081A patent/NZ581081A/xx not_active IP Right Cessation
- 2008-06-18 SI SI200831482T patent/SI2407475T1/sl unknown
- 2008-06-18 TW TW104118229A patent/TWI503396B/zh active
- 2008-06-18 EA EA201000032A patent/EA020806B1/ru unknown
- 2008-06-18 JO JOP/2008/0286A patent/JO3172B1/ar active
- 2008-06-18 EP EP11181831.6A patent/EP2407475B1/en active Active
- 2008-06-18 KR KR1020187031750A patent/KR102061001B1/ko active IP Right Grant
- 2008-06-18 EP EP15173458.9A patent/EP3002290B1/en active Active
- 2008-06-18 MY MYPI20095366A patent/MY160040A/en unknown
- 2008-06-18 WO PCT/US2008/067391 patent/WO2008157635A2/en active Application Filing
- 2008-06-18 CA CA2789109A patent/CA2789109C/en not_active Expired - Fee Related
- 2008-06-18 BR BRPI0813140A patent/BRPI0813140C1/pt not_active IP Right Cessation
- 2008-06-18 KR KR1020097026748A patent/KR20100031512A/ko active Application Filing
- 2008-06-18 MX MX2009013664A patent/MX2009013664A/es not_active Application Discontinuation
- 2008-06-18 KR KR1020167035728A patent/KR101863131B1/ko active IP Right Grant
- 2008-06-18 MX MX2012006571A patent/MX360094B/es unknown
- 2008-06-18 ES ES11181831.6T patent/ES2550504T3/es active Active
- 2008-06-18 CN CN201610262072.2A patent/CN106083969B/zh not_active Expired - Fee Related
- 2008-06-18 CR CR20170070A patent/CR20170070A/es unknown
- 2008-06-18 KR KR1020147035206A patent/KR101598402B1/ko active IP Right Grant
- 2008-06-18 KR KR1020187014779A patent/KR101916024B1/ko active IP Right Grant
- 2008-06-19 AR ARP080102625A patent/AR067440A1/es not_active Application Discontinuation
-
2009
- 2009-11-11 ZA ZA2009/07928A patent/ZA200907928B/en unknown
- 2009-11-18 IL IL202203A patent/IL202203B/en active IP Right Grant
- 2009-12-10 HK HK12106564.9A patent/HK1165807A1/xx not_active IP Right Cessation
- 2009-12-17 CR CR11174A patent/CR11174A/es unknown
-
2010
- 2010-01-13 SM SM201000003T patent/SMP201000003B/it unknown
-
2013
- 2013-01-18 JP JP2013007521A patent/JP5589102B2/ja not_active Expired - Fee Related
-
2015
- 2015-08-18 HR HRP20150879TT patent/HRP20150879T1/hr unknown
- 2015-09-22 CY CY20151100828T patent/CY1116700T1/el unknown
-
2016
- 2016-10-04 HK HK16111527.1A patent/HK1223372A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO3172B1 (ar) | تركيبة وطريقة وتحضير الصفراء الصناعية | |
JOP20180077A1 (ar) | تركيبات وطرق لحمض صفراوي تخليقي | |
WO2012021133A9 (en) | Synthetic bile acid compositions and methods | |
PH12016500216A1 (en) | Stable pharmaceutical composition and methods of using same | |
MY158504A (en) | Fatty acid niacin conjugates and their uses | |
MY166653A (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
MY166789A (en) | Arginine salts and their uses for the treatment of illnesses in the oral cavity | |
EP2528578A4 (en) | DENTAL COMPOSITION USING A CALCIUM SOURCE | |
UA96994C2 (ru) | Производные 7-алкинил-1,8-нафтиридонов, способ их получения и их применения в терапии | |
WO2010072787A3 (en) | A composition comprising a retinoid and method of treating skin conditions | |
MY155410A (en) | Compositions and devices | |
MX2011012479A (es) | Moduladores de los receptores 5-ht y metodos de uso de los mismos. | |
TN2009000447A1 (en) | An extented-release composition comprising a somatostatin derivative in microparticles | |
MX2009007265A (es) | Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion. | |
WO2009120700A3 (en) | Inhibition of dcps | |
BR112012016054A2 (pt) | Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico | |
WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
ATE448316T1 (de) | Verfahren zur herstellung einer zusammensetzung auf 4-hydroxyprolin-basis sowie verwendungen davon auf landwirtschaftlichem gebiet | |
MX2012002165A (es) | Acidos grasos modificados con silicona, metodo de preparacion y su uso de los mismos. | |
GEP20125563B (en) | 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same | |
DE602008002946D1 (de) | Beta-carbolinarylsulfonamide, verfahren zu ihrer h |